Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zambelli

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
Diagnostics (Basel, Switzerland)|October 25, 2024
The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [<sup>18</sup>F]FDG PET: Preliminary Results from a Prospective CohortFabrizia Gelardi, Lara Cavinato, Rita De Sanctis, et al.
BMJ Open|May 31, 2017
Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility studyAlessandro Passardi, Mimma Rizzo, Francesca Maines, et al.
Breast (Edinburgh, Scotland)|August 13, 2023
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in ItalyAlberto Zambelli, Marina Cazzaniga, Nicla La Verde, et al.
Cancer Treatment Reviews|February 1, 2014
Retinoids and breast cancer: from basic studies to the clinic and back againEnrico Garattini, Marco Bolis, Silvio Ken Garattini, et al.
Cancers|January 23, 2024
The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant ChemotherapyCorrado Tinterri, Bethania Fernandes, Alberto Zambelli, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
BRCA Testing for Patients Treated in Italy: A National Survey of Breast Centers Associated with SenonetworkCorrado Tinterri, Damiano Gentile, Francesco Caruso, et al.
Critical Reviews in Oncology/Hematology|March 10, 2024
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directionsRiccardo Gerosa, Rita De Sanctis, Flavia Jacobs, et al.
Critical Reviews in Oncology/Hematology|March 9, 2025
Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologistsMariangela Gaudio, Giulia Vatteroni, Rita De Sanctis, et al.
Frontiers in Oncology|March 23, 2023
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working groupLuca Licata, Deborah Cosentini, Rita De Sanctis, et al.
Anticancer Research|January 30, 2003
Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patientsAlberto Zambelli, Daniela Montagna, Gian Antonio Da Prada, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Diagnostics (Basel, Switzerland)|October 25, 2024
The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [<sup>18</sup>F]FDG PET: Preliminary Results from a Prospective CohortFabrizia Gelardi, Lara Cavinato, Rita De Sanctis, et al.
BMJ Open|May 31, 2017
Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility studyAlessandro Passardi, Mimma Rizzo, Francesca Maines, et al.
Breast (Edinburgh, Scotland)|August 13, 2023
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in ItalyAlberto Zambelli, Marina Cazzaniga, Nicla La Verde, et al.
Cancer Treatment Reviews|February 1, 2014
Retinoids and breast cancer: from basic studies to the clinic and back againEnrico Garattini, Marco Bolis, Silvio Ken Garattini, et al.
Cancers|January 23, 2024
The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant ChemotherapyCorrado Tinterri, Bethania Fernandes, Alberto Zambelli, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
BRCA Testing for Patients Treated in Italy: A National Survey of Breast Centers Associated with SenonetworkCorrado Tinterri, Damiano Gentile, Francesco Caruso, et al.
Critical Reviews in Oncology/Hematology|March 10, 2024
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directionsRiccardo Gerosa, Rita De Sanctis, Flavia Jacobs, et al.
Critical Reviews in Oncology/Hematology|March 9, 2025
Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologistsMariangela Gaudio, Giulia Vatteroni, Rita De Sanctis, et al.
Frontiers in Oncology|March 23, 2023
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working groupLuca Licata, Deborah Cosentini, Rita De Sanctis, et al.
Anticancer Research|January 30, 2003
Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patientsAlberto Zambelli, Daniela Montagna, Gian Antonio Da Prada, et al.
Pageof 17